|
Market Closed -
NSE India S.E.
14:05:09 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 11.50 INR | -3.60% |
|
-5.66% | -40.75% |
| 08-15 | Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh | CI |
| 08-14 | Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026 | CI |
Company Valuation: Nectar Lifesciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,171 | 5,393 | 3,577 | 6,761 | 5,147 | 1,807 |
| Change | - | 29.3% | -33.68% | 89.03% | -23.88% | -64.9% |
| Enterprise Value (EV) 1 | 12,945 | 13,810 | 10,936 | 12,914 | 10,769 | 555.6 |
| Change | - | 6.68% | -20.81% | 18.08% | -16.6% | -94.84% |
| P/E | -5.69x | 21.5x | -14.8x | 137x | -4.53x | -0.69x |
| PBR | 0.39x | 0.5x | 0.34x | 0.63x | 0.54x | 0.31x |
| PEG | - | -0x | 0x | -1x | 0x | -0x |
| Capitalization / Revenue | 0.27x | 0.32x | 0.23x | 0.4x | 0.31x | - |
| EV / Revenue | 0.84x | 0.83x | 0.72x | 0.77x | 0.64x | - |
| EV / EBITDA | 11.7x | 8.71x | 20.3x | 8.43x | -41.3x | -0.63x |
| EV / EBIT | 25.9x | 13.6x | -211x | 14x | -12.2x | -0.5x |
| EV / FCF | 6.19x | -28.1x | 42.1x | 13.3x | -63x | 0.11x |
| FCF Yield | 16.2% | -3.56% | 2.37% | 7.5% | -1.59% | 946% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3.27 | 1.117 | -1.08 | 0.22 | -5.07 | -13.4 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 15,433 | 16,689 | 15,237 | 16,841 | 16,704 | - |
| EBITDA 1 | 1,102 | 1,586 | 539.5 | 1,531 | -260.8 | -884.9 |
| EBIT 1 | 499.9 | 1,016 | -51.73 | 923.8 | -884.7 | -1,113 |
| Net income 1 | -732.6 | 250.5 | -241.8 | 49.95 | -1,137 | -2,929 |
| Net Debt 1 | 8,774 | 8,417 | 7,359 | 6,152 | 5,623 | -1,251 |
| Reference price 2 | 18.60 | 24.05 | 15.95 | 30.15 | 22.95 | 9.30 |
| Nbr of stocks (in thousands) | 224,261 | 224,261 | 224,261 | 224,261 | 224,261 | 194,261 |
| Announcement Date | 8/24/21 A | 8/24/22 A | 8/11/23 A | 8/14/24 A | 8/26/25 A | 8/20/26 A |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 23.38M | |
| 33.95x | 6.37x | 22.05x | 0.93% | 46.21B | |
| 16.25x | 2.01x | 8.92x | 1.63% | 38.78B | |
| 26.83x | 3.84x | 15.91x | 0.6% | 11.68B | |
| 26.59x | 3.22x | 16.68x | 0.95% | 11.55B | |
| 18.58x | 3.37x | 11.75x | 3.79% | 9.14B | |
| 9.22x | 2.13x | 5.5x | 4.82% | 7.3B | |
| 29.42x | 3.85x | 17.9x | 0.16% | 7.15B | |
| 14.96x | 1.94x | 6.45x | 3.37% | 7.1B | |
| Average | 21.98x | 3.34x | 13.15x | 2.03% | 15.44B | |
| Weighted average by Cap. | 24.29x | 3.90x | 14.87x | 1.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NECLIFE Stock
- Valuation Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions
